Biotech and pharmaceutical stocks rose after the November election, reflecting investor optimism that a Trump presidency would mean less focus on drug prices. Not so fast, President-elect Trump said in his interview for Time magazine's "Person of the Year." "I'm going to bring down drug prices,"...